Cullinan Oncology LLC

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$0
$0
$0
$0
Gross Profit
-79
-77
-76
EBITDA
-60,476
-50,531
-75,721
-54,920
EBIT
-60,244
-50,610
-75,798
-54,996
Net Income
-50,713
-50,610
-70,055
-48,501
Net Change In Cash
0
0
0
0
Free Cash Flow
-38,120
-36,915
-57,609
-43,155
Cash
88,332
103,335
72,820
76,655
Basic Shares
59,201
59,015
59,015
58,905

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-311
-306
-310
-93
EBITDA
-241,648
-167,152
-190,339
-132,044
EBIT
-241,959
-167,458
-190,649
-132,137
Net Income
-219,879
-167,383
-153,162
111,214
Net Change In Cash
0
0
0
0
Cost of Revenue
96,378
Free Cash Flow
-175,799
-145,303
-134,483
-127,797
Cash
88,332
83,005
98,434
156,152
Basic Shares
59,050
53,771
41,550
46,640

Earnings Calls

QuarterEPS
2025-12-31
-$0.77
2025-09-30
-$0.77
2025-06-30
-$1.19
2025-03-31
-$0.74